The prognostic and biological significance of cellular heterogeneity in medullary thyroid carcinoma: a study of calcitonin, L-dopa decarboxylase, and histaminase.

We evaluated the cellular distribution of calcitonin (CT), L-dopa decarboxylase (DDC), and histaminase [diamine oxidase (DAO)] in 33 patients with medullary thyroid carcinoma (MTC). CT immunostaining was uniform (greater than 90% of the cells) and intense (4+) in lesions from 7 patients with C-cell hyperplasia and 6 with microscopic MTC: conversely, patchy CT staining (less than 40% of the cells) and diminished intensity (1+) were found in metastases from 8 patients who died of virulent disease. In 17 patients who underwent thyroidectomy for macroscopic cervical MTC with no evidence distant metastases, CT staining was intense (3-4+) and homogeneous (greater than 90%) in 11 subjects who were well 0.5-16 yr postoperatively. Six patients with similar clinical presentations had heterogeneous staining for CT in primary tumor (less than 40% of the cells; 1-2+ intensity); 5 died of disseminated MTC 0.5-5 yr postoperatively (P less than 0.001). Biochemical studies of distant metastases revealed an inverse relationship between the distribution of CT and that of both relationship between the distribution of CT and that of both DDC (r = 0.71; P less than 0.01) and DAO (r = 0.81; P less than 0.001). We conclude that cellular heterogeneity in MTC tissue is associated with a distinct biochemical pattern, and its presence, whether in a primary or metastatic lesion, indicates a virulent neoplasm associated with a grave prognosis.

[1]  S. Baylin,et al.  Ectopic (inappropriate) hormone production by tumors: mechanisms involved and the biological and clinical implications. , 1980, Endocrine reviews.

[2]  J. Carney,et al.  C‐cell disease of the thyroid gland in multiple endocrine neoplasia, type 2B , 1979, Cancer.

[3]  D. Gann,et al.  Levels of histaminase and L‐dopa decarboxylase activity in the transition from C‐cell hyperplasia to familial medullary thyroid carcinoma , 1979, Cancer.

[4]  D. Trump,et al.  Discordance between plasma calcitonin and tumor-cell mass in medullary thyroid carcinoma. , 1979, The New England journal of medicine.

[5]  C. Kallman,et al.  The effects of L-dopa on in vitro and in vivo calcitonin release from medullary thyroid carcinoma. , 1979, The Journal of clinical endocrinology and metabolism.

[6]  J. Norton,et al.  Multiple endocrine neoplasia type IIb: the most aggressive form of medullary thyroid carcinoma. , 1979, The Surgical clinics of North America.

[7]  A. Tashjian,et al.  Calcitonin and carcinoembryonic antigen as tumor markers in medullary thyroid carcinoma. , 1978, American journal of clinical pathology.

[8]  S. Wells,et al.  Medullary Thyroid Carcinoma: Relationship of Method of Diagnosis to Pathologic Staging , 1978, Annals of surgery.

[9]  S. Wells,et al.  Provocative Agents and the Diagnosis of Medullary Carcinoma of the Thyroid Gland , 1978, Annals of surgery.

[10]  D. Ettinger,et al.  Variable content of histaminase, L-dopa decarboxylase and calcitonin in small-cell carcinoma of the lung. Biologic and clinical implications. , 1978, The New England journal of medicine.

[11]  S. Baylin,et al.  Association of diamine oxidase and ornithine decarboxylase with maturing cells in rapidly proliferating epithelium. , 1978, Biochimica et biophysica acta.

[12]  D. Gann,et al.  Calcitonin and histaminase in C-cell hyperplasia and medullary thyroid carcinoma. A light microscopic and immunohistochemical study. , 1978, The American journal of pathology.

[13]  S. Baylin,et al.  Inherited medullary thyroid carcinoma: a final monoclonal mutation in one of multiple clones of susceptible cells. , 1978, Science.

[14]  Y. Shimosato,et al.  Immunohistochemical and ultrastructural analysis of medullary carcinoma of the thyroid in relation to hormone production. , 1977, The American journal of pathology.

[15]  S. Hamada,et al.  Localization of carcinoembryonic antigen in medullary thyroid carcinoma by immunofluorescent techniques. , 1977, British Journal of Cancer.

[16]  D. Gann,et al.  Clonal origin of inherited medullary thyroid carcinoma and pheochromocytoma. , 1976, Science.

[17]  Khairi Mr,et al.  Mucosal neuroma, pheochromocytoma and medullary thyroid carcinoma: multiple endocrine neoplasia type 3. , 1975 .

[18]  A. Tashjian,et al.  Human calcitonin. Immunologic assay, cytologic localization and studies on medullary thyroid carcinoma. , 1974, The American journal of medicine.

[19]  D. Goltzman,et al.  Calcitonin as a tumor marker. Use of the radioimmunoassay for calcitonin in the postoperative evaluation of patients with medullary thyroid carcinoma. , 1974, The New England journal of medicine.

[20]  H. Keiser,et al.  Dopa decarboxylase in medullary carcinoma of the thyroid. , 1973, The New England journal of medicine.

[21]  A. Tashjian,et al.  C-cell hyperplasia preceding medullary thyroid carcinoma. , 1973, The New England journal of medicine.

[22]  N. Samaan,et al.  MEDULLARY (SOLID) CARCINOMA OF THE THYROID GLAND: AN ANALYSIS OF THE M. D. ANDERSON HOSPITAL EXPERIENCE WITH PATIENTS WITH THE TUMOR, ITS SPECIAL FEATURES, AND ITS HISTOGENESIS , 1973, Medicine.

[23]  A. Tashjian,et al.  Early diagnosis of medullary carcinoma of the thyroid gland by means of calcitonin assay. , 1971, The New England journal of medicine.

[24]  F. Sundler,et al.  Aromatic L-amino acid decarboxylase in calcitonin-producing cells. , 1971, Biochemical pharmacology.

[25]  A. Tashjian,et al.  Immunoassay of human calcitonin. , 1970, The New England journal of medicine.

[26]  P. Byfield,et al.  A radioimmunoassay for human calcitonin M. , 1969, Lancet.

[27]  A. Tashjian,et al.  Medullary carcinoma of the thyroid gland. Studies of thyrocalcitonin in plasma and tumor extracts. , 1968, The New England journal of medicine.

[28]  J. Meyer,et al.  Granules and thyrocalcitonin-like activity in medullary carcinoma of the thyroid gland. , 1968, The New England journal of medicine.

[29]  E. D. Williams,et al.  Histogenesis of medullary carcinoma of the thyroid , 1966, Journal of clinical pathology.

[30]  J. Hazard,et al.  Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity. , 1959, The Journal of clinical endocrinology and metabolism.